Status:
COMPLETED
Investigation of Acute Effects of Myofascial Trigger Point Release in Women With Chronic Pelvic Pain
Lead Sponsor:
Akdeniz University
Collaborating Sponsors:
Pamukkale University
Conditions:
Pelvic Pain
Pelvic Floor; Relaxation
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The patients diagnosed with pelvic pain will be included in the study. Orthopedic tests for pelvic pain were performed after routine gynecological examinations. After perineometer measurement, pelvic ...
Detailed Description
Turkey has been affected country from a busy and stressful lifestyle in our changing world and that leads to pelvic floor dysfunction has increased rapidly in Turkey. Pelvic pain that has in 1 out of ...
Eligibility Criteria
Inclusion
- The inclusion criteria:
- to have chronic pelvic pain for more than six months,
- to have 5 pelvic pain orthopedic tests (active straight leg raise (ASLR), flexion abduction external rotation (FABER), pelvic pain provocation (P4), long dorsal ligament palpation (LDL), The Gaenslen Test) and at least three of the tests are positive,
- to have good communication skills and accept to attend the study.
- The exclusion criteria:
- pregnant women who have had a pregnancy in the last year or who are breastfeeding;
- other causes of pain (eg pain unrelated to pelvic region relations, dermatological conditions, herpes, vulvovaginal atrophy);
- menopause;
- urogynecological conditions (i.e. pelvic prolapse grade \>3 according to the Pelvic Organ Prolapse - Quantification method (POP-Q) or a urinary or vaginal infection active or present in the last 3 months);
- history of pelvic floor surgery (e.g. corrective surgery for organ descent, urinary incontinence, hysterectomy, mesh surgery,TVT,TOT);
- previous pelvic floor rehabilitation treatments; 7) expected changes in medication that may affect the perception of pain (eg pain relievers, antidepressants);
- any other medical conditions that may interfere with the study procedures (eg hormonal, psychological, cardiovascular, hematological, neurological, pulmonary or renal);
- refusal to abstain from other treatments until the end of their participation in the study.
Exclusion
Key Trial Info
Start Date :
August 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04401566
Start Date
August 21 2018
End Date
May 2 2021
Last Update
January 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alime Buyuk
Antalya, Turkey (Türkiye), 07070